Literature DB >> 26923972

[Non-alcoholic fatty liver disease (NAFLD) /non-alcoholic steatohepatitis (NASH) and nutrition].

Kiyo-aki Ishii1, Toshinari Takamura2.   

Abstract

Non-alcoholic fatty liver disease (NAFLD) is characterized by excessive fat accumulation in the form of triglycerides in the hepatocytes. A more severe form of NAFLD with necrosis, inflammation, and fibrosis is called non-alcoholic steatohepatitis (NASH). The liver is located in the center of the body's organ network and acts as a coordinator of glucose and lipid metabolism. Therefore, it is important to perform nutritional therapy of patients with NAFLD/NASH while maintaining the energy balance in the entire body.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26923972     DOI: CliCa1603363367

Source DB:  PubMed          Journal:  Clin Calcium        ISSN: 0917-5857


  2 in total

1.  Quantitative proteomics analysis based on tandem mass tag labeling coupled with labeling coupled with liquid chromatography-tandem mass spectrometry discovers the effect of silibinin on non-alcoholic fatty liver disease in mice.

Authors:  Yichao Wang; Hang Zhao; Liying Yang; He Zhang; Xian Yu; Wenjie Fei; Yunfeng Zhen; Zhe Gao; Shuchun Chen; Luping Ren
Journal:  Bioengineered       Date:  2022-03       Impact factor: 6.832

2.  2,3,5,4'-tetrahydroxy-stilbene-2-O-β-D-glucoside attenuates methionine and choline-deficient diet-induced non-alcoholic fatty liver disease.

Authors:  Mingnuan Han; Ting Zhang; Wen Gu; Xingxin Yang; Ronghua Zhao; Jie Yu
Journal:  Exp Ther Med       Date:  2018-06-13       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.